Skip to main content

Table 4 The logistic regression analysis of efficacy prediction for serum inflammation indexes in ESCC receiving anti-PD1 plus chemotherapy

From: Combining serum inflammation indexes at baseline and post treatment could predict pathological efficacy to anti‑PD‑1 combined with neoadjuvant chemotherapy in esophageal squamous cell carcinoma

 

OR (95% CI)

P value

LMR at baseline

  ≤ 3.173

1.00

 

  > 3.173

3.881E8 (0.000-)

0.998

S II at post treatment of second period

  ≤ 174.574

1.00

 

  > 174.574

9.563E8 (0.000-)

0.999

PLR at post treatment of third period

  ≤ 151.516

1.00

 

  > 151.516

0.083 (0.009–0.782)

0.030